IP Library Patent Application 14503745
Patent Application
App. No. 14/503,745

REVERSE GENETICS METHODS FOR VIRUS RESCUE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/503,745
Abstract

A method for rescuing a virus by reverse genetics is provided in which cells are added after transfection.

Claims (29)

1 - 28 . (canceled)

29 . A method for preparing a viral composition, the method comprising the steps of:

(i) transfecting a culture eukaryotic cells with at least one expression construct encoding a viral RNA molecule;

(ii) adding untransfected eukaryotic cells to the transfected cells of step (i) to provide a mixture of cells, wherein the untransfected cells are of the same type as the cells of step (i);

(iii) culturing the mixture of cells from step (ii) so as to produce viruses in the culture; and,

(iv) harvesting viruses, proteins or combination thereof from the culture obtained in step (iii), so as to obtain a viral composition.

30 . The method of claim 29 , further comprising a step of:

(v) purifying the viruses from step (iv) so as to obtain purified virions.

31 . The method of claim 30 , wherein the virions obtained in step (v) is whole virions.

32 . The method of claim 30 , further comprising inactivating the viruses or the purified virions.

33 . The method of claim 31 , further comprising packaging the whole virions in a sterile container.

34 . The method of claim 33 , wherein the viral composition further comprises an adjuvant.

35 . A kit comprising the whole virions of claim 33 .

36 . The kit of claim 34 , further comprising an adjuvant component provided in a separate container.

37 . The method of claim 30 , further comprising a step of:

treating the purified virions with a detergent so as to obtain split virions.

38 . The method of claim 37 , further comprising inactivating the split virions.

39 . The method of claim 37 , further comprising packaging the split virions in a sterile container.

40 . The method of claim 39 , wherein the viral composition further comprises an adjuvant.

41 . A kit comprising the split virions of claim 37 .

42 . The kit of claim 40 , further comprising an adjuvant component provided in a separate container.

43 . The method of claim 29 , wherein the proteins of step (iv) are one or more surface antigens.

44 . The method of claim 43 , further comprising a step of:

purifying the one or more surface antigens so as to obtain purified surface antigens.

45 . The method of claim 43 , further comprising inactivating the surface antigens.

46 . The method of claim 44 , further comprising packaging the purified surface antigens in a sterile container.

47 . The method of claim 44 , wherein the viral composition further comprises an adjuvant.

48 . A kit comprising the surface antigens of claim 46 .

49 . The kit of claim 47 , further comprising an adjuvant component provided in a separate container.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2016
From: NOVARTIS AG
To: SEQIRUS UK LIMITED
Reel/Frame 039335/0937 →